Atomoxetine Attenuates Dextroamphetamine Effects in Humans
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although preclinical studies support the contribution of the noradrenergic system activation in mediating the acute effects of amphetamines, these findings have not been followed up in clinical studies. OBJECTIVES: To examine the effects of atomoxetine, a norepinephrine transporter inhibitor, on subjective, physiological, and plasma cortisol responses to dextroamphetamine in 10 healthy volunteers. METHODS: Subjects were randomly assigned to a sequence of atomoxetine (40 mg/day) or placebo treatments each lasting for 4 days. On Day 4 of each treatment period, responses to a single 20 mg/70 kg dose of dextroamphetamine were assessed. RESULTS: Atomoxetine treatment attenuated dextroamphetamine-induced increases in systolic and diastolic blood pressure and plasma cortisol as well as the self-report ratings of "stimulated," "high," and "good drug effects." CONCLUSIONS: These findings are consistent with previous preclinical studies supporting the role of the noradrenergic system in mediating acute amphetamine responses. SCIENTIFIC SIGNIFICANCE: Atomoxetine's capacity to attenuate some of the physiological and subjective responses to dextroamphetamine supports its potential use for stimulant addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endocrinology of the stress response
Charmandari, E., Tsigos, C., & Chrousos, G. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120816 · Cited by 1,799 · cited 1×
“The mechanism for the cortisol release is thought to be mediated by norepinephrine’s capacity to increase corticotrophin releasing hormone (CRH) at the paraventricular nucleus of the hypothalamus (14).”
BackgroundBymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Kuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617 · cited 1×
“Further recent preclinical studies demonstrated that in doses equivalent to those used clinically, amphetamines release both norepinephrine and dopamine in the prefrontal cortex accompanied by minimal increases of dopamine in the nucleus accumbens (5).”
BackgroundStimulants: Therapeutic Actions in ADHD
Arnsten, A. F. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301164 · Cited by 473 · cited 1×
“These findings further support the contribution of the noradrenergic system activation in mediating the acute effects of amphetamines (6).”
Result
Cited by
Toxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
Treuer, T., Gau, S. S.-F., Méndez, L., Montgomery, W., Monk, J. A., Altin, M., Wu, S., Lin, C. C. H., & Dueñas, H. J. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0093 · Cited by 58
Baird, A. L., Coogan, A. N., Kaufling, J., Barrot, M., & Thome, J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.03.038 · Cited by 46
“…of these processes are dysregulated in ADHD (e.g. Baird et al., 2011) and are also known to be regulated by both MPD and ATO (Boonstra et al., 2007; Sofuoglu et al., 2009), it appears plausible that MPD and ATO action on circadian processes in the DMH and PVN may be of consequence in such…”
BackgroundZlebnik, N. E., & Carroll, M. E. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3744-6 · Cited by 28
Strajhar, P., Vizeli, P., Patt, M., Dolder, P. C., Kratschmar, D. V., Liechti, M. E., & Odermatt, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.016 · Cited by 17
“107 D-Amphetamine at low oral doses of 10-20 mg has been repeatedly shown to increase plasma 108 and saliva cortisol concentrations [16, 25-31], with no effect on plasma cortisol levels [32].”
Metadata
- Authors
- Sofuoglu, M., Poling, J., Hill, K., & Kosten, T.
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 2009-12-15
- Volume
- 35
- Issue
- 6
- Pages
- 412-416
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- OpenAlex
- W2043908990
- Cited by
- 35
- References
- 5
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atomoxetine Attenuates Dextroamphetamine Effects in Humans. https://app.cochat.ai/papers/10.3109/00952990903383961
- The paper
- Sofuoglu, M., Poling, J., Hill, K., & Kosten, T. (2009). Atomoxetine Attenuates Dextroamphetamine Effects in Humans. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.3109/00952990903383961
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.